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Abstract
Antibiotic resistance is an increasingly serious public health threat1. Understanding pathways 
allowing bacteria to survive antibiotic stress may unveil new therapeutic targets2–8. We explore the 
role of the bacterial epigenome in antibiotic stress survival using classical genetic tools and single-
molecule real-time sequencing to characterize genomic methylation kinetics. We find that 
Escherichia coli survival under antibiotic pressure is severely compromised without adenine 
methylation at GATC sites. While the adenine methylome remains stable during drug stress, 
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without GATC methylation, methyl-dependent mismatch repair (MMR) is deleterious, and fueled 
by the drug-induced error-prone polymerase PolIV, overwhelms cells with toxic DNA breaks. In 
multiple E. coli strains, including pathogenic and drug-resistant clinical isolates, DNA adenine 
methyltransferase deficiency potentiates antibiotics from the β-lactam and quinolone classes. This 
work indicates that the GATC methylome provides structural support for bacterial survival during 
antibiotics stress and suggests targeting bacterial DNA methylation as a viable approach to 
enhancing antibiotic activity.
Bacteria exposed to antibiotics mount complex stress responses that promote survival9–14, 
and accumulating evidence suggests that inhibiting such responses potentiates antimicrobial 
activity in drug-sensitive, tolerant and resistant organisms2,3,5,8,15–18. In both prokaryotes 
and eukaryotes, genetic pathways underlying responses to environmental insults have been 
widely studied and involve some of the most phylogenetically conserved proteins known19. 
In eukaryotes, stress can also elicit epigenetic modification of histones and DNA that 
support long-lasting downstream responses20–23. The role of prokaryotic epigenomes in 
stress, however, is much less clear.
Bacteria lack histones, but harbor a diverse group of enzymes able to insert epigenetic 
modifications in the form of sequence-specific methylation of DNA bases24. Prokaryotic 
DNA methyltransferases (MTases) function either alone or as part of restriction-modification 
systems, participating in various cellular processes including anti-viral defense, cell cycle 
regulation, DNA replication and repair, and transcriptional modulation24–26. While several 
methylation-dependent epigenetic switches have been described27–32, genome-wide 
methylation patterns and kinetics have, until recently, been difficult or impossible to study in 
a high-throughput manner33–36. In this study, we use genetic and genomic tools to explore 
the function and behavior of the bacterial methylome during antibiotic stress.
To assess the role of DNA methylation in antibiotic stress survival, we first tested the ability 
of E. coli lacking different MTases to withstand sub-lethal doses of β-lactam antibiotics. 
Laboratory E. coli K12 possesses four functional MTases that methylate adenines or 
cytosines within distinct target sequences24,36–40 (Fig. 1a). Survival of sub-inhibitory 
ampicillin exposure by log-phase E. coli was unaffected in mutants lacking HsdM, YhdJ or 
Dcm MTases. However, bacteria deficient in DNA adenine methyltransferase (Dam) were 
highly susceptible to this low drug dose (Fig. 1b and Sup. Fig. 1a,b). Increased ampicillin 
susceptibility in dam-deficient E. coli was also reflected in a reduced minimum inhibitory 
concentration (MIC) and minimum bactericidal concentration (MBC) (Sup. Fig. 1c). 
Complementation with a plasmid expressing dam, but not gfp, restored wild-type survival 
levels in Δdam E. coli (Fig. 1c, Sup. Fig. 2a, b). Because Dam might also behave as a 
transcriptional repressor independently of its DNA methyltransferase function37, we tested 
the ability of plasmids expressing previously characterized methylation-incompetent Dam 
variants38 (Sup. Fig. 2a) to rescue ampicillin hypersensitivity in Δdam E. coli. Consistent 
with a role for GATC methylation, mutant Dam expression minimally altered the ampicillin 
hypersensitivity of Δdam E. coli, if at all (Sup. Fig. 2b, c). Finally, we sought to determine 
whether Δdam E. coli hypersensitivity extended to drugs other than ampicillin. Sub-
inhibitory treatment with aztreonam, meropenem and cephalexin, other β-lactams commonly 
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used in the clinic, was also significantly potentiated in the absence of dam (Fig. 1d). 
Together, these results suggest that Dam-dependent methylation is important for bacterial 
survival during β-lactam stress.
Dam methylates GATC sites throughout the genome of organisms belonging to multiple 
orders of γ-proteobacteria, including the clinically relevant genera Escherichia, Salmonella, 
Yersinia and Vibrio24. To explore the behavior of the Dam methylome in the context of 
antibiotic pressure, we extracted genomic DNA from E. coli growing in the presence or 
absence of ampicillin stress, and analyzed genome-wide GATC methylation over time using 
single molecule real-time (SMRT) sequencing. With SMRT technology, epigenetic 
modifications on template DNA strands are inferred through the unique kinetic signature 
they engender during sequencing35,39, and the fraction of DNA molecules methylated 
(‘frac’) at each GATC site is estimated (Fig. 2a). In all samples, consistent with Dam’s 
processive kinetics40, the majority of GATC sites were detected as methylated in a high 
fraction of DNA molecules sequenced (0.97±0.05 on average) (Fig. 2b, Sup. Data Set 1). 
Notably, during the log-to-stationary phase transition, we identified 19 GATC sites that 
appeared transiently or stably non-methylated, or hemimethylated (Fig. 2c, d; Sup. Table 1, 
2; Sup. Data Set 1). Transiently non-methylated sites typically became steadily more or less 
methylated over time, following clear temporal patterns (Fig. 2c, d). Because prokaryotes 
lack demethylases, non-methylated GATC sequences exist mainly where DNA-binding 
proteins sterically hinder Dam activity immediately following DNA replication24. Consistent 
with this notion, 18 of these 19 sites fell within intergenic regions, mostly overlapping with 
or closely neighboring footprints of transcription factors (Sup. Table 1). To our knowledge, 
only five of these sites have been previously reported as protected24,41–44.
Remarkably, the GATC methylome and its kinetics were largely unaltered by ampicillin 
stress. The genome-wide distribution of frac values was similar in treated and untreated cells 
over time, indicating that global methylation levels were not increased or decreased by drug 
exposure (Fig. 2b). Furthermore, methylation at the vast majority of GATC sites, including 
those displaying dynamic methylation patterns, remained unchanged by treatment (Fig. 2d, 
Sup. Table 2, Sup. Data Set 1). Comparison of treated versus untreated samples at each 
timepoint revealed only one GATC site (site 19) displaying statistically significant 
differential methylation, which occurred at a single timepoint and only on one strand (Sup. 
Table 2, Sup Fig. 3). This event’s biological consequence is unclear, however, as expression 
of the surrounding gene (gdhA) was unperturbed by ampicillin treatment (data not shown). 
Thus, ampicillin stress does not majorly alter the E. coli Dam methylome.
Given the remarkable stability of adenine methylation during antibiotic exposure and the 
contrasting drug-sensitive phenotype of dam-deletion mutants, we reasoned that the GATC 
methylome must provide structural rather than regulatory support for bacterial survival 
during antibiotic stress. Widespread genomic Dam methylation enables cellular processes 
requiring discrimination between the fully methylated parental DNA strand, and newly 
synthesized DNA whose GATC sites are not yet modified45. Specifically, transient 
hemimethylation at replication forks orients the methyl-dependent mismatch repair (MMR) 
system, guiding replacement of mismatched bases to nascent DNA strands only46. 
Importantly, without GATC methylation, the methyl-dependent endonuclease MutH can 
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introduce double-strand breaks (DSB) near mismatches targeted for repair47–51. Mismatches 
are rare in log-phase E. coli52 (<1 per replication cycle), but under conditions of stress, their 
frequency can increase due in part to induction of the error-prone polymerase IV (PolIV, 
encoded by dinB)53–55. We thus hypothesized that potentiation of β-lactam killing in the 
absence of Dam was a result of drug-induced mutagenesis fueling a genotoxic MMR 
pathway.
To test this, we assessed the effect of deleting dinB, mutH or the mismatch-binding 
component of the MMR complex, mutS, on antibiotic hypersensitivity in Δdam bacteria. 
Strikingly, without the mutagenic polymerase PolIV, Δdam E. coli survival of ampicillin 
stress returned to wild-type levels (Fig 3a; Sup. Fig. 4a). Similarly, removal of mutS or 
mutH on the Δdam background also abrogated ampicillin hypersensitivity (Fig. 3b, Sup. Fig. 
4b). In ΔmutH Δdam bacteria, optical density (OD) was somewhat diminished in ampicillin 
(Sup. Fig. 4b), but this did not reflect decreased viability during treatment (Fig. 3b). Further 
consistent with our hypothesis, we found that Δdam, but not ΔdinB Δdam or ΔmutH Δdam 
bacteria, developed significantly more DNA damage than wild-type cells during ampicillin 
treatment, as assessed by terminal deoxynucleotidyl transferase nick end-labeling 
(TUNEL)56 (Fig. 3c, d). Thus, without the GATC methylome, β-lactam-elicited PolIV 
introduces mismatches that are converted into lethal DNA strand breaks by a deleterious 
MMR system (Fig. 3e).
The finding that genomic GATC methylation supports β-lactam stress survival in E. coli 
evokes the possibility of targeting Dam to therapeutically potentiate antibiotic drug activity. 
Dam is an attractive target as it lacks mammalian homologs but is conserved in several 
enteric pathogens57–59. Furthermore, because muliple drugs can induce mutagenic responses 
in bacteria9,12,55,60–62, treatment with antibiotics other than β-lactams should also be 
potentiated in the absence of GATC methylation. Indeed, survival of dam-deficient E. coli in 
the presence of sub-inhibitory doses of the quinolones norfloxacin, ofloxacin and 
ciprofloxacin was severely compromised compared to wild-type bacteria (Fig. 4a). As seen 
with ampicillin, hypersensitivity to ofloxacin could be abrogated by deleting dinB, mutH or 
mutS, in Δdam E. coli (Sup. Fig. 5a, b). Consequently, drug potentiation in the absence of 
GATC methylation occurs via a similar mechanism across different antibiotic classes, and 
may be broadly exploitable.
Next, we sought to determine whether virulent clinical isolates could also be sensitized to 
treatment by the removal of Dam. As in E. coli K12, dam deletion in uropathogenic E. coli 
(UPEC) UTI8963 significantly increased sensitivity to ciprofloxacin (Fig. 4b). Ciprofloxacin 
is a valuable drug for UPEC treatment, but its use is increasingly restricted by the spread of 
quinolone resistance64. To assess whether targeting Dam might allow re-sensitization of 
resistant strains, we deleted dam in a highly ciprofloxacin resistant (CiproR) clinical UPEC 
isolate bearing multiple common quinolone resistance-conferring mutations (Sup. Table 3). 
Remarkably, though dam deletion did not restore full sensitivity to this isolate, the 
ciprofloxacin MIC for CiproR UPEC was reduced by over half, and its MBC90 by 4.6 fold 
(Fig. 4c). Thus, removing GATC methylation can potentiate antibiotic lethality in both drug-
sensitive and drug-resistant pathogenic organisms.
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Together, our results define an important structural role for the bacterial epigenome in 
antibiotic stress survival. Characterization of the adenine methylome revealed highly stable 
global GATC methylation levels during log-to-stationary phase transition and sub-inhibitory 
β-lactam stress, and while we identified several previously uncharacterized GATC sites with 
variable methylation over time, antibiotic stress did not significantly alter these patterns.
Despite the remarkable stability of the GATC methylome, E. coli lacking Dam are 
hypersensitive to antibiotic stress. Deletion of E. coli dcm or Neisseria meningitides 
Mod11A (an adenine Mtase) was also reported to alter bacterial sensitivity to toxic 
compounds, but increased resistance, not hypersensitivity, was observed, and attributed to 
altered gene expression36,69. While we cannot exclude additional involvement of 
transcriptional dysregulation, our data suggest that the GATC methylome represents an 
important backbone structure enabling DNA repair processes to function in the context of β-
lactam and quinlone stress. Specifically, GATC methylation likely supports antibiotic-
elicited mutagenesis dependent on PolIV, an error-prone polymerase induced 
transcriptionally or post-translationally in the presence of several antibiotics53–55. In the 
absence of GATC methylation, MMR machinery can convert post-replicative mismatches to 
DSBs47, which accumulate to toxic levels in mutagenizing drug-exposed dam-deficient 
bacteria. In Δdam E. coli, the DNA damage response program (SOS) is constitutively sub-
induced65. dinB is within the SOS regulon66,67, thus Δdam E. coli may be primed for rapid 
PolIV synthesis, enhancing their sensitivity. In addition, DNA breaks caused by MMR in 
mutating, drug-exposed Δdam bacteria likely promote SOS pathway induction further, 
leading to more PolIV activity68. Consequently, during antibiotic stress, a toxic feedback 
loop may establish itself (Fig. 3e). This model is consistent with earlier observations that 
DNA-damaging agents cause MMR-dependent genotoxicity in Δdam bacteria49,50,69–71; 
however, our data further suggest that any initial DNA damage caused by antibiotics directly 
is not sufficient kill Δdam bacteria, as the error-prone PolIV is required for hypersensitivity 
(Fig. 3a and Sup. Fig. 5a). Measuring mutagenesis rates in Δdam bacteria is challenging 
(due to MMR toxicity to mutating cells) and we cannot completely exclude a requirement 
for PolIV in introduction of initial DNA damage. This seems unlikely, however, given that 
similar levels of damage were recorded in wild-type and ΔdinB bacteria during drug 
treatment (Fig. 3d). Thus, our data support a model in which antibiotic stress becomes lethal 
as mutagenic PolIV activity fuels a genotoxic MMR response in the absence of GATC 
methylation.
Our findings raise the possibility of targeting Dam to enhance the therapeutic activity of 
existing drugs. Several classes of antibiotics induce mutagenesis at sub-inhibitory 
concentrations9,12,55,60–62, and may thus be subject to potentiation by this mechanism. 
While enhancement of drug activity could be harnessed to lower effective therapeutic doses 
in drug-sensitive infections, it may also allow re-sensitization of resistant organisms. Indeed, 
our data suggest that targeting Dam methylation can partially reverse ciprofloxacin 
resistance in UPEC. More broadly, this observation suggests that mutagenic stress responses 
can occur and be therapeutically exploited in highly drug-resistant pathogenic organisms. In 
addition to drug potentiation, inhibiting Dam has been proposed as a strategy to weaken 
bacterial pathogenicity in vivo25,72–74, as GATC methylation controls virulence gene 
expression in some organisms. While elevated rates of mutagenesis and induction of certain 
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prophages75 in the absence of Dam could complicate a Dam inhibitor-based monotherapy, 
these drawbacks may be mitigated in the context of combination treatment. In summary, our 
results suggest that targeting bacterial epigenomic structures that support mutagenic stress 
responses may be a viable strategy to enhancing antibiotic activity.
Online methods
Bacterial strains and plasmids
Laboratory bacterial strains used are derived from E. coli K12 (BW25113 obtained from the 
Coli Genetic Stock Center or MG1655 obtained from ATCC). The uropathogenic E. coli 
strain UTI89 was kindly provided to us from Matt Conover and Scott Hultgren. The 
ciprofloxacin-resistant uropathogenic E. coli isolate (UPEC CiproR) was collected from the 
Brigham and Women’s Hospital Specimen bank (Sup. Table 3). Deletion mutants on the 
BW25113 background were derived from the KEIO collection following KanR cassette 
removal. Deletion mutants on the MG1655 background were constructed by allelic 
transduction from KEIO collection strains using classical P1 phage transduction, followed 
by KanR cassette excision. The dam null phenotype was confirmed by PCR alone or with 
electrophoresis of genomic DNA digested with DpnII, which cleaves unmethylated GATC 
sites only. For construction of the Δdam UTI89 and Δdam UPEC CipoR strains, the parent 
strain bearing a KM208 plasmid-based Red-recombinase system was electroporated with a 
PCR amplicon encoding the Δdam::KanR allele. Recovered cells were selected for 
kanamycin-resistant homologous recombinants. The plasmid was cured and the KanR 
cassette was removed. The genotype of each deletion strain was verified by colony PCR. 
The plasmid used in the dam complementation studies, namely pZS*31 (Fig. 1c, Sup. Fig. 
2), was obtained from Expressys and belongs to the pZ vector family. pZS*31 has a 
pSC101* origin of replication (which yields a low copy number of 3–5 plasmids per cell) 
and a chloramphenicol-resistance marker. Genes encoding either Dam (with 500bp upstream 
flanking region) or GFP were inserted into the multiple cloning site. For complementation 
experiments using mutated versions of dam, the plasmid containing the dam insert was 
engineered using either Gibson cloning or site-directed mutagenesis (NEB, Q5 site-directed 
mutagenesis kit). Quinolone resistance-conferring mutations in the CipoR UPEC clinical 
isolate were identified though whole-genome Illumina sequencing of genomic DNA 
(PureLinK Pro-96 Genomic Purification Kit; Life Technologies). Libraries were prepared as 
previously described76. Raw sequencing reads were processed by trimming adapter 
sequences and discarding reads shorter then 28bp. Processed reads were aligned to the E. 
coli MG1655 genome using breseq77. The genome alignments were searched for known 
quinolone resistance-conferring mutations in acrA, acrR, beaS, cpxA, cpxB, envZ, gyrA, 
gyrB, marA, marR, mdtA, mdtB, mdtC, ompC, ompF, ompR, parC, parE, soxR, soxS and 
tolC genes and their regulatory regions.
Bacterial kill curves, MBC and MIC determination
For timecourse kill curves and MBC assays, stationary-phase bacterial cultures were diluted 
at 1:1,000 in 25mLs of LB medium in 250mL baffled flasks. Cultures were grown at 37°C 
and 200rpm until they reached an OD of ~0.3. Cultures were transferred to 24-well plates at 
500 μl per well, or to 96-well plates at a final volume of 150ul per well, and either left 
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untreated or treated with the indicated drugs at specified doses. Plates were sealed using 
breathable membranes (BreatheEasy, Cat #: BEM-1) and incubated at 37°C and 900rpm for 
the remainder of the experiment. CFUs were enumerated at desired time points (4 hours for 
MBC determination) by spot plating 5 μl of ten-fold serially diluted culture onto LB agar 
and counting colonies after overnight growth at 37°C. Percent survival at each timepoint was 
calculated in relation to the CFU immediately before treatment (0h). For MIC determination, 
antibiotics were serially diluted in a 96-well plate and mixed with stationary-phase bacterial 
cultures diluted at 1:10,000 in a final volume of 150 μl LB per well. OD was measured from 
plates after 24hrs of growth at 900rpm and 37C.
Genomic DNA extraction and PacBio sequencing
Genomic DNA (gDNA) was extracted from E. coli K12 MG1655 LB cultures grown in the 
presence or absence of ampicillin using the GenElute Bacterial Genomic DNA Extraction 
Kit (Sigma). To assess genomic methylation status, gDNA extracted from stationary-phase 
cultures was quantified, digested using DpnII (NEB) and run on an 0.8% agarose gel 
containing ethidium bromide. For methylome analyses, samples were sent to UMass 
Medical School Deep Sequencing Core, where methylome data were obtained by PacBio 
Core Enterprise instrument SMRT. SMRTbell™ DNA template libraries for SMRT 
sequencing were prepared according to the instructions described in the ‘Procedure & 
Checklist for 10 kb Template Preparation and Sequencing’ document (Pacific Biosciences). 
Briefly, genomic DNA samples were first sheared to a target shear size of 10kb using g-Tube 
devices (Covaris, Inc.), treated with DNA damage repair mix, end-repaired and ligated to 
hairpin adapters. The SMRTbell libraries were prepared using the DNA Template Prep Kit 
2.0 (3–10kb) fro Pacific Biosciences. Incompletely formed SMRTbell templates were 
digested using Exonuclease III (New England Biolabs) and Exonuclease VII (Affymetrix). 
The prepared SMRTbell libraries were sequenced using a 120-min movie acquisition time 
and P4 polyerase-C2 DNA sequencing reagent kits following standard instructions for a 
PacBio RS II instrument (Pacific Biosciences). Each E. coli sample was sequenced on four 
or more SMRT cells yielding a total of approximately 200-fold double-stranded coverage of 
the bacterial genome, and two or three biological replicates were sequenced for each 
antibiotic treatment condition (Sup. Data Set 2). Sequencing coverage was comparable 
between methylated and non-methylated sites (Sup. Table 1, Sup. Data Set 2), ruling out 
coverage loss as an explanation for the absence of methylation.
Bioinformatics analyses of SMRT sequencing data
Genome-wide detection of base modification and the affected motifs was performed using 
the standard (default) settings in the ‘RS_Modification_and_Motif_Analysis.1’ protocol 
included in SMRT Analysis version 2.3.0 Patch 5. The FASTA reference genome sequence 
(E. coli K12 MG1655, NCBI NC_000913.2) used for the base modification detection 
analyses was obtained from Pacific Biosciences. For motif identification, the base 
modification Quality Value (QV) threshold setting was left at the default value of 30. 
Interpulse duration (IPD) values were measured for all nucleotide positions in the genome 
and compared with expected durations in an in silico kinetic model of the polymerase for 
significant associations. ‘Frac’ values were calculated in SMRT Analysis using a standard 
mixture model analysis of the pooled kinetic data for a given sample. The frac output value 
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provides information about the fraction of individual molecules displaying a methylation 
signal at each identified motif site within the genome (Sup. Data Set 1). Methylation frac 
values were derived from IPD data within the SMRT pipeline using the single site mixture 
model39. The value 0 was substituted for frac values that were below detection limits. The 
values from two or three experimental replicates were compared by Student’s T-test and 
FDR adjusted p-values were obtained by the method of Benjamini and Hochberg (Sup. Data 
Set 1). Circular graphs were generated using the Circos software package 
Flow cytometric assessment of DNA damage
E. coli log-phase cultures were transferred to a 96-well plate (200 μl/well) and treated with 
ampicillin (2.5 μg/mL) or hydrogen peroxide (100mM) for 30 minutes to 2 hours at 37°C 
and 900rpm. Bacteria were pelleted by centrifugation at 3,000× g for 5 minutes. The 
supernatant was discarded. Cell pellets were resuspended vigorously in 200 μl of cold 4% 
paraformaldehyde/PBS and incubated at room temperature for 30 minutes to allow fixation. 
Bacteria were centrifuged again, then resuspended in 200 μl of cold permeabilization buffer 
(0.1%TritonX-100 in 0.1% sodium citrate). After 2 minutes at room temperature, bacteria 
were centrifuged and washed in PBS. After pelleting the cells and discarding the 
supernatant, cells were resuspended in 50 μl of TUNEL labeling mix (dUTP-FITC and TdT 
enzyme) or 50 μl TUNEL labeling reagent (dUTP-FITC) according to manufacturer’s 
instructions (Roche; in situ cell death detection kit, fluorescein). Bacteria were stained for 1h 
at 37°C. Cells were then washed twice with PBS, resuspended in 1 μg/mL PI/PBS and 
analyzed by flow cytometry (BD LSR Fortessa). PI negative cells, which lack genomic 
material, were excluded from the analysis. Gating was determined using single color and 
unstained controls as references. For Fig. 3d and statistical analysis, background staining 
with labeling reagent only was subtracted for each sample to account for treatment 
dependent shifts in auto-fluorescence or stain retention.
Statistical analyses
Statistical analysis performed on log10-transformed data (for survival experiments) or on 
untransformed data (for TUNEL assay) using a two-way ANOVA followed by a post-hoc t-
test using Sidak’s multiple comparison test correction. In all cases, p-values indicated are 
multiplicity adjusted.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Increased sensitivity to β-lactams in the absence of dam methylation
a. DNA methylation in E. coli K12: methylated DNA bases, methyltransferases (MTases) 
and their respective target sequences. b. Wild type (wt) or MTase-deficient E. coli BW25113 
were grown in lysogeny broth (LB) to an OD of 0.3, then treated with 2.5 μg/mL of 
ampicillin (~0.5 × MIC) or left untreated. c. Log-phase wild-type or dam-deficient E. coli 
harboring the indicated Cmr plasmid expressing either dam or gfp were cultured in 
chloramphenicol (15 μg/mL)-supplemented LB with or without ampicillin (2.5 μg/mL). d. 
wild-type or Δdam E. coli grown to an OD of 0.3 were treated for 4h with the indicated 
drugs. Azt, aztreonam; Mer, meropenem; Ceph, cephalexin. In b–d, survival was determined 
by monitoring colony-forming units (CFU) in bacterial cultures at the indicated timepoints, 
and is expressed relative to CFU at 0h. Mean percent survival ± SEM of n = 3 independent 
experiments is shown; ns, not significant; *, p<0.05, **, p<0.01; ***, p<0.001; ****, 
p<0.0001.
Cohen et al. Page 13
Nat Genet. Author manuscript; available in PMC 2016 September 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Kinetics of the Dam methylome during normal growth or under antibiotic stress
Genomic DNA extracted from wild-type E. coli MG1655 growing with or without 
ampicillin (2.5 μg/mL) was analyzed by SMRT sequencing for genome-wide GATC 
methylation over 4h. Methylation is shown as the average fraction of sequenced molecules 
methylated for each GATC site, or ‘frac;’ dottted red lines indicate the limit of detection 
(0.25) a. Representative frac data for untreated bacteria; X-axis, position on selected 
genomic segment; arrows non-methylated (black) or hemimethylated (orange) GATC sites. 
b. Genome-wide frac distributions during growth in LB (solid line, gray fill) or ampicillin 
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(dashed line, no fill) over time; mean frac ± SD are shown. c. Genome-wide kinetics of 
adenine methylation at GATC sites during log-to-stationary phase growth in LB; black lines 
indicate frac values as shown in (a); colored hashes show the position of genes either 
strands; the innermost ring is a reference map of genomic positions in megabases; oriC, 
origin of replication; colored indicators on the outer most ring highlight sites detected as 
non-methylated (frac<0.025, coefficient of variation<0.5) in at least one sample set, with 
colors corresponding to methylation increase (red) or decrease (blue) over time, stable non-
methylation (black), hemimethylation (orange) or other (gray). d. Methylation kinetics for 
untreated (solid line) and ampicillin-treated (dotted line) E. coli at GATC positions that are 
non-methylated in at least one sample; x axis, time; mean frac ± SEM of n = 2–3 
independent experiments is shown.
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Figure 3. PolIV-dependent mutagenesis fuels MMR-mediated DNA damage in β-lactam-
stressedΔdam E. coli
a–b. The indicated E. coli BW25113 strains were grown in LB to an OD of 0.3, then treated 
with ampicillin (2.5 μg/mL) or left untreated. CFU in bacterial cultures were monitored 
hourly to assess survival. Mean percent survival ± SEM of n = 2 independent experiments is 
shown. c. Log-phase E. coli grown in LB alone, with hydrogen peroxide (100 mM) or with 
ampicillin (2.5 μg/mL) for the indicated time were assayed for DNA breaks by terminal 
deoxynucleotidyl transferase (TdT) nick end labeling (TUNEL). The fluorescence 
distribution of each sample incubated with fluorescent label in the presence (solid line) or 
absence (shaded histogram) of TdT is displayed. A representative experiment is shown; 
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MFI, mean fluorescence intensity. d. DNA damage as assessed as in (c) at 1hr. Mean percent 
DNA damage positive ± SEM of n = 3 independent experiments is shown; statistical 
comparisons between each mutant strain and wild-type were not significant unless otherwise 
indicated; ****, p<0.0001. e. Schematic model of antibiotic potentiation in the absence of 
Dam methylation.
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Figure 4. Quinolone toxicity is potentiated in laboratory and pathogenic Δdam E. coli
a. wild-type or Δdam E. coli BW25113 grown to an OD of 0.3 were treated for 3h with or 
without the indicated drugs. b. Log-phase UTI89 uropathogenic E. coli (UPEC) or Δdam 
UTI89 was treated with 15ng/mL of ciprofloxacin or left untreated. Mean percent survival 
(compared to t = 0h) ± SEM of n = 2 independent experiments is shown. c. Determination of 
ciprofloxacin MIC, left panel, and MBC90, right panel, for CiproR UPEC by broth 
microdilution in LB. wild-type and Δdam MIC are 133 μg/mL and 59 μg/mL, respectively; 
wild-type and Δdam MBC90 are 316 μg/mL and 68 μg/mL, respectively. Dotted lines 
indicate cut-off values for MIC (OD<0.1) or MBC90 (10% survival), MBC90 values were 
interpolated using a sigmoidal curve fit model as shown. In a–c, means ± SEM of n = 2–3 
independent experiments is shown; ns, not significant; ****, p<0.0001.
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